Evidence map›Paper›PMID 41502865›Full record

ReviewThe Lancet regional health. Europe2026

Inequalities in availability of clinical trials for pediatric, adolescent, and young adult patients with cancer in Europe: results from the SIOPE OCEAN project.

Kerstin K Rauwolf, Teresa de Rojas, Miguel Martins, Maria Otth, Uta Dirksen, Delphine Heenen, Lejla Kameric, Pamela Kearns, Ruth Ladenstein, Cormac Owens and 5 more

Abstract readReview
In one paragraph

Review in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kerstin K RauwolfDepartment of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
Teresa de RojasACCELERATE, Brussels, Belgium.
Miguel MartinsPaediatrics Department, Instituto Português de Oncologia Lisboa Francisco Gentil, Lisboa, Portugal.
Maria OtthDepartment of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
Uta DirksenPediatrics III, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Delphine HeenenKickCancer, Belgium.
Lejla KamericChildhood Cancer International, Europe.
Pamela KearnsInstitute of Cancer and Genomic Sciences, NIHR Birmingham Biomedical Research Centre, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
Ruth LadensteinSt Anna Children's Hospital and Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.
Cormac OwensDepartment of Oncology, Children's Health Ireland at Crumlin, Dublin, Ireland.
Caroline QueirozSIOPE, Brussels, Belgium.
Richard SullivanKing's Institute of Cancer Policy, United Kingdom.
Carmelo RizzariPediatric Hematology-Oncology Unit IRCSS Foundation San Gerardo dei Tintori, Monza, Italy.
Gilles VassalGustave Roussy Comprehensive Cancer Centre and Paris-Saclay University, Villejuif, France.
European Society for Paediatric Oncology (SIOPE)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are pronounced inequalities in outcomes of children, adolescents, and young adults (AYA) with cancer across Europe. The OCEAN project aimed at describing the availability of clinical trials for this population, the inequalities between countries, and propose solutions to reduce these disparities. The ClinicalTrials.gov database was searched to identify all European cancer clinical interventional studies including patients <18 years with a start date between 2010 and 2022. The study included 436 cancer-directed trials in 38 European countries. More than half were academic-sponsored (55%), and 49% included exclusively pediatric/AYA patients. Important differences in available trial numbers per country were identified, with more trials observed in Northern and Western Europe as compared to Eastern Europe. There is an urgent need to address differences in clinical trials availability both at European and national levels to advance equity and improve care, research and access to innovation for all pediatric/AYA patients with cancer in Europe. Funding: This work has been performed as part of WP6 on inequalities in cancer research of the 4.UNCAN.eu Coordination and Support Action (#101069496) funded by the European Union and has been supported by Zoé4Life (MO).

Indexed as

Clinical trialsEuropeInequalitiesPediatric cancer

Identifiers

PMID41502865
PMCPMC12771080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.